New drug for lowering 'bad' cholesterol
A significant development in the medical field offers a new alternative for patients facing problems with high cholesterol. It is the drug inclisiran, which promises to effectively help manage the levels of 'bad' cholesterol in the blood.
The function of this specific drug differs significantly from the traditional statins that are widely used to this day. While statins act by reducing cholesterol synthesis directly in the liver, inclisiran follows a different mechanism. Specifically, the drug acts by inhibiting the production of a specific protein that prevents the body from removing cholesterol from the blood.
The introduction of this treatment is considered particularly important for patients in Greece, as cardiovascular diseases are one of the main causes of health problems in the population. The possibility of a new therapeutic approach offers hope to those who do not respond sufficiently to conventional treatments or show intolerance to them.
Experts point out that the use of the new drug should always be done upon medical advice and monitoring. Despite scientific progress, proper nutrition and regular physical exercise remain the key pillars for maintaining good heart and vascular health.